Skip to content
Intrinsic value · Buy/Sell verdict · scores — free· 500 Nifty 500 stocks· EOD 2026-06-15

Saregama India Ltd

SAREGAMA · NSE · Communication Services

₹462.6
+6.75 (+1.48%)
Our verdict
Buy68/100
Quality77
Valuation39
Momentum91
Financial trend75
Intrinsic value
Our fair value
₹431.57
Fairly valued
Price ₹462.6Range ₹312.4₹550.73

With a 20% margin of safety, our buy-below price is ₹345.25.

A
Financial health 100/100
Altman Z 9.5 · Safe zone

Piotroski F-score 3/9 — quality of earnings & balance sheet.

Investability checklist

Passed 9 of 13 checks69/100
  • ROE above 15%12.6%
  • Low debt (D/E < 0.5)0.04x
  • Positive free cash flow
  • Revenue growth > 10%19%
  • Earnings growing24%
  • Net margin ≥ 10%21.0%
  • Current ratio > 1.51.75
  • Below our fair value
  • Margin of safety ≥ 20%
  • Above 200-day average
  • Above 50-day average
  • Positive 1-year return
  • Altman Z in safe zoneZ 9.5
  • Piotroski ≥ 73/9

1-year price

EOD · 2026-06-15
1W
+1.2%
1M
+11.3%
3M
+33.1%
6M
+28.0%
1Y

Our scores

Durability77
Valuation39
Momentum91
Analyst consensus target ₹489.5 (+6%) · 4 analysts

Key fundamentals

Market cap
₹8,880 Cr
P/E ratio
43.2
P/B ratio
5.34
EPS (TTM)
₹10.71
ROE
12.6%
Debt / Equity
0.04x
Profit margin
21.0%
Free cash flow
₹403 Cr
52-week high
₹537.17
-13.88% from high
52-week low
₹311.1
Dividend yield
2.0%
Beta
0.60

SWOT snapshot

Strengths

  • Lightly leveraged balance sheet.
  • Healthy profit margin (21.0%).
  • Financially solid — Altman Z 9.5.

Weaknesses

  • Weak Piotroski score (3/9).

Opportunities

  • Earnings growing (24% YoY).
  • Revenue growing (19% YoY).

About Saregama India Ltd

Saregama India Limited operates as an entertainment company in India and internationally. It operates in four segments: Music, Artist Management, Video, and Events. The Music segment engages in the manufacture and sale of music storage device through Carvaan, Music Card, Vinyl records, etc., as well as dealing with related music rights

More in Media Entertainment & Publication

Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.